CDXS
Price
$2.50
Change
-$0.22 (-8.06%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
246.43M
58 days until earnings call
GOVX
Price
$0.74
Change
-$0.01 (-1.33%)
Updated
Sep 2, 04:58 PM (EDT)
Capitalization
18.91M
Interact to see
Advertisement

CDXS vs GOVX

Header iconCDXS vs GOVX Comparison
Open Charts CDXS vs GOVXBanner chart's image
Codexis
Price$2.50
Change-$0.22 (-8.06%)
Volume$11.08K
Capitalization246.43M
GeoVax Labs
Price$0.74
Change-$0.01 (-1.33%)
Volume$1.07K
Capitalization18.91M
CDXS vs GOVX Comparison Chart in %
Loading...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDXS vs. GOVX commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a Hold and GOVX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (CDXS: $2.73 vs. GOVX: $0.75)
Brand notoriety: CDXS and GOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 47% vs. GOVX: 16%
Market capitalization -- CDXS: $246.43M vs. GOVX: $18.91M
CDXS [@Biotechnology] is valued at $246.43M. GOVX’s [@Biotechnology] market capitalization is $18.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 0 FA rating(s) are green whileGOVX’s FA Score has 0 green FA rating(s).

  • CDXS’s FA Score: 0 green, 5 red.
  • GOVX’s FA Score: 0 green, 5 red.
According to our system of comparison, CDXS is a better buy in the long-term than GOVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 3 TA indicator(s) are bullish while GOVX’s TA Score has 5 bullish TA indicator(s).

  • CDXS’s TA Score: 3 bullish, 5 bearish.
  • GOVX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, GOVX is a better buy in the short-term than CDXS.

Price Growth

CDXS (@Biotechnology) experienced а -5.37% price change this week, while GOVX (@Biotechnology) price change was -2.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

CDXS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDXS($246M) has a higher market cap than GOVX($18.9M). CDXS YTD gains are higher at: -42.767 vs. GOVX (-69.814). GOVX has higher annual earnings (EBITDA): -24.71M vs. CDXS (-52.78M). CDXS has more cash in the bank: 66.3M vs. GOVX (3.09M). GOVX has less debt than CDXS: GOVX (195K) vs CDXS (69M). CDXS has higher revenues than GOVX: CDXS (57.2M) vs GOVX (6.14M).
CDXSGOVXCDXS / GOVX
Capitalization246M18.9M1,302%
EBITDA-52.78M-24.71M214%
Gain YTD-42.767-69.81461%
P/E RatioN/AN/A-
Revenue57.2M6.14M931%
Total Cash66.3M3.09M2,143%
Total Debt69M195K35,385%
FUNDAMENTALS RATINGS
CDXS vs GOVX: Fundamental Ratings
CDXS
GOVX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5791
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDXS's Valuation (41) in the Chemicals Specialty industry is in the same range as GOVX (50) in the null industry. This means that CDXS’s stock grew similarly to GOVX’s over the last 12 months.

CDXS's Profit vs Risk Rating (100) in the Chemicals Specialty industry is in the same range as GOVX (100) in the null industry. This means that CDXS’s stock grew similarly to GOVX’s over the last 12 months.

CDXS's SMR Rating (99) in the Chemicals Specialty industry is in the same range as GOVX (100) in the null industry. This means that CDXS’s stock grew similarly to GOVX’s over the last 12 months.

CDXS's Price Growth Rating (57) in the Chemicals Specialty industry is somewhat better than the same rating for GOVX (91) in the null industry. This means that CDXS’s stock grew somewhat faster than GOVX’s over the last 12 months.

CDXS's P/E Growth Rating (100) in the Chemicals Specialty industry is in the same range as GOVX (100) in the null industry. This means that CDXS’s stock grew similarly to GOVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDXSGOVX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 19 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
84%
Aroon
ODDS (%)
Bullish Trend 5 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTEX9.580.48
+5.27%
Mannatech
GLDG0.93N/A
+0.34%
GoldMining
VMC291.16N/A
N/A
Vulcan Materials Company(Holding Company)
AMLX9.38-0.04
-0.42%
Amylyx Pharmaceuticals
VEON58.53-2.16
-3.56%
VEON Ltd

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with DNLI. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
+0.37%
DNLI - CDXS
51%
Loosely correlated
-2.43%
BEAM - CDXS
50%
Loosely correlated
-2.91%
PRAX - CDXS
49%
Loosely correlated
-0.98%
CRSP - CDXS
47%
Loosely correlated
-2.30%
IPSC - CDXS
46%
Loosely correlated
-1.68%
More

GOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOVX has been loosely correlated with OGEN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GOVX jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOVX
1D Price
Change %
GOVX100%
+0.15%
OGEN - GOVX
35%
Loosely correlated
-7.90%
VICP - GOVX
31%
Poorly correlated
N/A
PROK - GOVX
31%
Poorly correlated
-5.60%
CDXS - GOVX
29%
Poorly correlated
+0.37%
KYTX - GOVX
29%
Poorly correlated
+0.27%
More